Katherine Johnson

2.2k total citations
30 papers, 723 citations indexed

About

Katherine Johnson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Katherine Johnson has authored 30 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Genetics. Recurrent topics in Katherine Johnson's work include Muscle Physiology and Disorders (8 papers), RNA modifications and cancer (5 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Katherine Johnson is often cited by papers focused on Muscle Physiology and Disorders (8 papers), RNA modifications and cancer (5 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Katherine Johnson collaborates with scholars based in United States, United Kingdom and Germany. Katherine Johnson's co-authors include Bhagwat Prasad, Jashvant D. Unadkat, Caroline Lee, John L. Lewis, Jeffrey J. Gaynor, Patricia E. Saigo, Joanna M. Cain, Edward J. Kelly, Jonathan Himmelfarb and Sarah Billington and has published in prestigious journals such as Neuron, Nature Immunology and Journal of Molecular Biology.

In The Last Decade

Katherine Johnson

29 papers receiving 705 citations

Peers

Katherine Johnson
Carol Donovan United States
Ying‐Hong Feng United States
Qing Wu China
Wang Fen China
Qing Yan China
Anh Diep United States
Katherine Johnson
Citations per year, relative to Katherine Johnson Katherine Johnson (= 1×) peers Hideaki Kusaka

Countries citing papers authored by Katherine Johnson

Since Specialization
Citations

This map shows the geographic impact of Katherine Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Johnson more than expected).

Fields of papers citing papers by Katherine Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Johnson. The network helps show where Katherine Johnson may publish in the future.

Co-authorship network of co-authors of Katherine Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Johnson. A scholar is included among the top collaborators of Katherine Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Johnson. Katherine Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Katherine, et al.. (2025). Mammalian Queuosine tRNA Modification Impacts Translation to Enhance Cell Proliferation and MHC-II Expression. Journal of Molecular Biology. 437(16). 169188–169188.
2.
Takahama, Michihiro, Ashwini Patil, Katherine Johnson, et al.. (2024). A pairwise cytokine code explains the organism-wide response to sepsis. Nature Immunology. 25(2). 226–239. 34 indexed citations
3.
Liu, Jingyi, Otis Pinkard, Helen C. Miranda, et al.. (2022). Suppression of premature transcription termination leads to reduced mRNA isoform diversity and neurodegeneration. Neuron. 110(8). 1340–1357.e7. 11 indexed citations
4.
Zaki, Maha S., Katherine Johnson, Jennifer McEvoy‐Venneri, et al.. (2020). Bi-allelic TTC5 variants cause delayed developmental milestones and intellectual disability. Journal of Medical Genetics. 58(4). 237–246. 5 indexed citations
5.
Becker, Lena‐Luise, Hormos Salimi Dafsari, Jens Schallner, et al.. (2020). The clinical-phenotype continuum in DYNC1H1-related disorders—genomic profiling and proposal for a novel classification. Journal of Human Genetics. 65(11). 1003–1017. 31 indexed citations
6.
Lemmers, Richard J.L.F., Nienke van der Stoep, Patrick J. van der Vliet, et al.. (2019). SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain. Journal of Medical Genetics. 56(10). 693–700. 23 indexed citations
7.
Milev, Miroslav P., Daniela Stanga, Anne Schänzer, et al.. (2019). Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein. Scientific Reports. 9(1). 14036–14036. 9 indexed citations
8.
Łusakowska, Anna, Jakub Fichna, Katherine Johnson, et al.. (2019). ANO5 mutations in the Polish limb girdle muscular dystrophy patients: Effects on the protein structure. Scientific Reports. 9(1). 11533–11533. 12 indexed citations
9.
Strang‐Karlsson, Sonja, Katherine Johnson, Ana Töpf, et al.. (2018). A novel compound heterozygous mutation in the POMK gene causing limb-girdle muscular dystrophy-dystroglycanopathy in a sib pair. Neuromuscular Disorders. 28(7). 614–618. 8 indexed citations
10.
Prasad, Bhagwat, Deepak Bhatt, Katherine Johnson, et al.. (2018). Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study. Drug Metabolism and Disposition. 46(7). 943–952. 72 indexed citations
11.
Perić, Stojan, Ana Töpf, Dušanka Savić‐Pavićević, et al.. (2017). A novel recessive TTN founder variant is a common cause of distal myopathy in the Serbian population. European Journal of Human Genetics. 25(5). 572–581. 13 indexed citations
12.
Bergh, Peter Van den, Yves Sznajer, Ron A. Wevers, et al.. (2017). A homozygous DPM3 mutation in a patient with alpha-dystroglycan-related limb girdle muscular dystrophy. Neuromuscular Disorders. 27(11). 1043–1046. 7 indexed citations
13.
Johnson, Katherine, Ana Töpf, Marta Bértoli, et al.. (2017). Identification of GAA variants through whole exome sequencing targeted to a cohort of 606 patients with unexplained limb-girdle muscle weakness. Orphanet Journal of Rare Diseases. 12(1). 173–173. 17 indexed citations
14.
Prasad, Bhagwat, Katherine Johnson, Sarah Billington, et al.. (2016). Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics. Drug Metabolism and Disposition. 44(12). 1920–1924. 114 indexed citations
15.
Prasad, Bhagwat, Marc Vrana, Aanchal Mehrotra, Katherine Johnson, & Deepak Bhatt. (2016). The Promises of Quantitative Proteomics in Precision Medicine. Journal of Pharmaceutical Sciences. 106(3). 738–744. 32 indexed citations
16.
Johnson, Katherine, Louise N. Reynard, & John Loughlin. (2015). Functional characterisation of the osteoarthritis susceptibility locus at chromosome 6q14.1 marked by the polymorphism rs9350591. BMC Medical Genetics. 16(1). 81–81. 13 indexed citations
17.
Akula, Nirmala, Jennifer J. Barb, Jens R. Wendland, et al.. (2014). RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Molecular Psychiatry. 19(11). 1179–1185. 82 indexed citations
18.
Liu, Xibao, Hwei Ling Ong, Biswaranjan Pani, et al.. (2010). Effect of cell swelling on ER/PM junctional interactions and channel assembly involved in SOCE. Cell Calcium. 47(6). 491–499. 13 indexed citations
19.
Mann, J. John, et al.. (1990). Acute effects of single and repeated electroconvulsive therapy on plasma catecholamines and blood pressure in major depressive disorder. Psychiatry Research. 34(2). 127–137. 23 indexed citations
20.
Saigo, Patricia E., et al.. (1986). Prognostic factors in adenocarcinoma of the uterine cervix. Cancer. 57(8). 1584–1593. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026